Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

aXichem

1.22 SEK

0.00 %

Less than 1K followers

AXIC A

First North Stockholm

Chemicals

Basic Materials

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
0.00 %
-8.27 %
-40.63 %
-48.15 %
-60.36 %
+5.03 %
-82.41 %
-96.53 %
-92.72 %

aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company works mainly with Phenylcapsaicin, a natural analogue synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, and among individual pharmaceutical work areas. Operations are conducted on a global level, with headquarters in Malmö.

Read more
Market cap
82.63M SEK
Turnover
20.96K SEK
Revenue
18.45M
EBIT %
-94.8 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
21/5
2026

Interim report Q1'26

17/6
2026

General meeting '26

27/8
2026

Interim report Q2'26

All
Press releases
3rd party
ShowingAll content types
Regulatory press release3/10/2026, 11:50 AM

aXichem AB: aXichem genomför en riktad emission av units till garant i samband med den genomförda företrädesemissionen

aXichem
Regulatory press release3/10/2026, 11:50 AM

aXichem AB: aXichem carries out a directed issue of units to guarantor in connection with the completed rights issue

aXichem
Regulatory press release3/2/2026, 3:00 PM

aXichem AB: aXichem announces final outcome of the rights issue

aXichem

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release3/2/2026, 3:00 PM

aXichem AB: aXichem offentliggör slutligt utfall i företrädesemissionen

aXichem
Regulatory press release2/27/2026, 5:00 PM

aXichem AB: aXichem offentliggör preliminärt utfall i företrädesemissionen

aXichem
Regulatory press release2/27/2026, 5:00 PM

aXichem AB: aXichem announces preliminary outcome of the rights issue

aXichem
Regulatory press release2/19/2026, 7:30 AM

aXichem AB (publ), Bokslutskommuniké, januari - december 2025

aXichem
Regulatory press release2/19/2026, 7:30 AM

aXichem AB (publ), Year End Report, January - December 2025

aXichem
Press release2/16/2026, 12:30 PM

aXichem AB: aXichems VD Torsten Helsing presenterar rapport för fjärde kvartalet 2025 i en direktsänd webbkonferens

aXichem
Press release2/16/2026, 12:30 PM

aXichem AB: aXichem's CEO Torsten Helsing Presents the Report for the Fourth Quarter 2025 in a Live Web Conference

aXichem
Press release2/13/2026, 8:00 AM

aXichem AB: aXichem publishes information memorandum and initiates subscription period

aXichem
Press release2/13/2026, 8:00 AM

aXichem AB: aXichem offentliggör informationsmemorandum och inleder teckningsperiod

aXichem
Regulatory press release2/3/2026, 9:00 PM

aXichem AB: aXichem carries out a rights issue of units of approximately SEK 11 million

aXichem
Regulatory press release2/3/2026, 9:00 PM

aXichem AB: aXichem genomför företrädesemission av units om cirka 11 MSEK

aXichem
Press release1/29/2026, 7:30 AM

aXichem AB: aXichem comments request from EFSA regarding the company's Feed Additive application in EU for phenylcapsaicin

aXichem
Press release1/29/2026, 7:30 AM

aXichem AB: aXichem kommenterar begäran från EFSA rörande bolagets ansökan om godkännande som fodertillsats för phenylcapsaicin i EU

aXichem
Press release1/20/2026, 11:30 AM

aXichem AB: aXichem updates status regarding the company's Feed Additive application in EU for phenylcapsaicin

aXichem
Press release1/20/2026, 11:30 AM

aXichem AB: aXichem uppdaterar statusen gällande företagets ansökan om godkännande som fodertillsats för phenylcapsaicin i EU

aXichem
Press release1/15/2026, 10:00 AM

aXichem AB: aXichem Announces Publication of CrossFit Study in Leading Sports Journal - Validates aXivite as a High-Intensity Performance Supplement

aXichem
Press release1/15/2026, 10:00 AM

aXichem AB: aXichems studie inom CrossFit publicerad i ledande vetenskaplig tidskrift för sport - bekräftar aXivite som prestationshöjande tillskott vid högintensiv träning

aXichem
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.